228 filings
Page 2 of 12
8-K
31tlq8d20 zmy
4 Jan 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:04pm
8-K
j7ry2ia4tqg0q7g v2
9 Nov 22
Lexicon Pharmaceuticals Reports Third Quarter 2022
4:05pm
8-K
pf44 b6aqyxg
2 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
4t65gl60qdj5 rf
2 Aug 22
Lexicon Pharmaceuticals Reports Second Quarter 2022
4:07pm
8-K
kfwliaub68h0ys392l
29 Jul 22
Lexicon Announces Proposed Public Offering of Common Stock
5:18pm
8-K
2qnm3 cau45yjnap
30 Jun 22
Lexicon Announces Positive Top-line Results from Phase 2 Proof-of-concept Study of LX9211 In Painful Diabetic Neuropathy
12:52pm
8-K
ro1jv
25 May 22
Material Modifications to Rights of Security Holders
8:27am
8-K
gi6z5u3v ti5
5 May 22
Lexicon Pharmaceuticals Reports First Quarter 2022
6:10am
8-K
94v77xo
17 Mar 22
Entry into a Material Definitive Agreement
4:17pm
8-K
y79v3o
28 Feb 22
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Clinical Update
6:17am
8-K
ftxelm
3 Nov 21
Lexicon Pharmaceuticals Reports Third Quarter 2021
4:05pm
8-K
hyuadn9ymt4rvqaw7wm
9 Sep 21
Departure of Directors or Certain Officers
4:10pm
8-K
o6rwraqhbjy qz88
2 Aug 21
Departure of Directors or Certain Officers
7:23am
8-K
lz2g0jx3
2 Aug 21
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
7:20am
8-K
fjq ge5d5au86ich
30 Jul 21
Results of Operations and Financial Condition
7:52am
8-K
978l90qsnvg0dqit9d
30 Jul 21
Departure of Directors or Certain Officers
7:12am
8-K
prsjv96q
6 May 21
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
r3nhm0akb9zjlxoy mgk
3 May 21
Entry into a Material Definitive Agreement
4:08pm
8-K
4s8g yrlk058
1 Apr 21
Departure of Directors or Certain Officers
4:36pm
8-K
263jo1csq
10 Mar 21
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Provides Clinical Update
4:12pm